在门诊心脏病诊所进行脂蛋白测试:质量改善倡议
1Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, United States (Gruen).
Journal of clinical lipidology
|February 15, 2026
概括
升高的脂蛋白 (a) [Lp (a) ]会增加心血管疾病的风险. 一项质量改进计划成功地使心脏病诊所的Lp (a) 测试率翻了一番,确定了更多的风险患者.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 升高的脂蛋白 (Lp) 是动脉样硬化心血管疾病的重要危险因素.
- 指南建议对成年人进行普遍的Lp (a) 测试.
- 目前的Lp (a) 测试率不足于最佳水平.
研究的目的:
- 实施和评估质量改进 (QI) 计划,以提高Lp (a) 测试率.
- 评估提供者教育和基于EHR的工具对Lp (a) 订单的影响.
- 为了确定有资格接受未来Lp(a) 向治疗的患者.
主要方法:
- 在一般心脏病学研究员诊所进行了一项QI项目.
- 干预措施包括提供者教育和集成基于EHR的订单工具.
- 数据是在10个月的时间内收集的.
主要成果:
- 患有Lp(a) 顺序的患者比例从10.1%增加到20.9%.
- 患有Lp(a) 结果的患者比例从7.0%增加到11.2%.
- 在QI倡议中,Lp (a) 测试显著增加.
结论:
- 质量改进方法可以有效地提高Lp (a) 测试率.
- 识别患有升高Lp (a) 的患者对于预防心血管疾病至关重要.
- 卫生系统应该为广泛的Lp测试和向治疗做好准备.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
649
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
649
Coronary Artery Disease V: Interprofessional Care
307
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Atherosclerosis III: Management
459
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459
Coronary Artery Disease IV: Preventive Measures
737
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
737
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
586
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
586
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
462
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
462


